Forbes

Zepbound Vs. Ozempic For Weight Loss: What’s The Difference?

Janese Laster, M.D. Gastroenterology / Nutrition / Obesity Medicine / Bariatric Endoscopist Dr. Janese Laster is a physician quadruple board-certified in internal medicine, gastroenterology, obesity ...
STAT

I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’

Dushay is an assistant professor of medicine at Harvard Medical School and an attending endocrinologist at Beth Israel Deaconess Medical Center. Microdosing GLP-1s for cosmetic weight loss: Patients ...
The Indianapolis Star

CVS adds weight-loss drug, Zepbound, back to preferred coverage

Nearly a year after CVS Caremark dropped Eli Lilly's blockbuster Zepbound from its standard coverage plan, causing anxiety for thousands of patients and prescribers, the pharmacy benefit manager ...
MarketWatch

Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans

Eli Lilly’s stock closed at a record high after the drugmaker disclosed that one of the nation’s most powerful pharmacy-benefit managers will start covering its popular GLP-1 medications later this ...
USA Today

CVS will add these weight-loss options to drug plans

CVS Health announced it will reinstate coverage of Eli Lilly's blockbuster weight-loss injectable Zepbound and begin coverage of the anti-obesity pill Foundayo for millions of Americans on private ...
FOX 5 Atlanta

CVS Caremark to cover Zepbound again after lawsuit, widespread backlash

CVS Caremark is reversing course a year after it removed the obesity drug Zepbound from its formularies. The nation’s largest pharmacy benefits manager said it will add Zepbound back to ...
NBC New York

CVS Caremark will cover Lilly's weight loss drug Zepbound again after patient backlash

CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lilly said Thursday. CVS Caremark is one of ...
Bloomberg L.P.

CVS Returns Zepbound to Drug Plans After Lilly Slashes Price

More than 10 million US patients will regain easy access to Eli Lilly & Co.’s obesity shot Zepbound through insurance after CVS Health Corp. reversed a controversial decision to restrict it for ...
U.S. News & World Report

CVS Brings Back Coverage for Lilly's Obesity Drug Zepbound

May 28 (Reuters) - CVS Health will restore Eli ⁠Lilly's ⁠weight-loss injection Zepbound to its list ⁠of covered drugs and add the drugmaker's newly approved obesity pill, Foundayo, it said on Thursday ...
Honolulu Star-Advertiser

CVS restores Eli Lilly Zepbound weight loss drug coverage

CVS Health will restore Eli Lilly’s weight-loss injection Zepbound to its list of covered drugs and also add the drugmaker’s newly approved obesity pill, Foundayo, it said today. CVS Caremark, one of ...
AOL

Foundayo and Zepbound now covered for millions of Americans

Eligible patients may pay as low as $25 a month for their medicine INDIANAPOLIS, May 28, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an access milestone in obesity care: all ...
Forbes

Zepbound vs. Mounjaro For Weight Loss: What’s The Difference?

Meaghan is an editor and writer who also has experience practicing holistic medicine as an acupuncturist and herbalist. She's passionate about helping individuals live full, healthy and happy lives at ...